“Semantic Intelligence” receives a grant

“Semantic Intelligence” has recently received a grant under the EU-funded “BOWI” (Boosting Widening Digital Innovation Hubs) project, which will enable it to keep growing and to develop another solution– automatic data curation technology.

Today, about 88% of the data encountered every day is textual or unstructured data. This volume of data is relentlessly growing, by about 62% per year. For several years, the “Semantic Intelligence” team has been developing large-volume data analysis technology for the life sciences, specifically the pharmaceuticals and biochemistry sectors. They are working on a next-generation patent analysis platform, which brings together five AI technologies, from text analysis (which encompasses natural language processing) to machine learning and deep linguistic analysis. There have also been adapted technologies to comprehend text context, understand chemical compound formulas, and recognize images. The method for combining these five technologies is currently being patented. 

One of the most finicky yet essential stages of drug development is making sure that a specific chemical compound hasn’t been published or patented yet. It often takes three to four years from publishing a patent to a scientific publication, so it is impossible to solely rely on scientific publications. “Our goal is to create an instrument for the pharmaceutical industry which makes the everyday life of the researchers significantly easier. It’s a kind of “google” for patents,” says Vita Stūre, the founder of “Semantic Intelligence”.

Under the BOWI project, the team has developed a special module for automatic data curation or data pre-processing technology, which will be integrated into the patent analysis platform as well as being available as a separate web service. Up to now, this technology has only been tested on small databases, but thanks to the BOWI project, it has been optimized and scaled for large-scale, industrial-level databases.

“Semantic Intelligence” team of seven people includes four full-time staff and three advisors who are involved in the firm’s operations at the strategic level. While the company is registered in Latvia, the team has specialists from Russia, Sweden, Switzerland, and Spain. “Our team works remotely full time. For this arrangement to work, trust is vital and every staff member must be passionate. It would not be possible to assemble the type of team we have entirely in Latvia. We see ourselves as a global enterprise – there are no borders in our world, and that is the way it should be,” says Vita.

“Semantic Intelligence” was founded in 2017 as an AI start-up, with the aim of supporting the digital transformation of the life sciences sector. The firm’s solutions provide a platform for enterprises in the pharmaceuticals, biochemistry, and other life science industries involving artificial intelligence technologies, including natural language processing, machine learning, deep linguistic analysis, chemical compounds analysis, and image recognition.

Source: labsoflatvia.com